Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
BEVYXXA (BETRIXABAN) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
BEVYXXA
NDA
Get alerts
BETRIXABAN | N208383 | PORTOLA PHARMACEUTICALS INC
2 strengths
5 unique patents
0 unique exclusivities
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
DMF
Approvals
Label
Products
Patent Timeline
5 unique patents by expiration date
All strengths
40MG
80MG
Expiring < 1yr (2)
Active (3)
Today
2027
2028
2029
2030
2031
Today
7598276
Nov. 8, 2026
8404724
Mar. 29, 2031
8557852
Sep. 8, 2028
8987463
Dec. 28, 2030
9555023
Nov. 7, 2026
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (2)
Sort:
Name
↑
Applicant
Strength
Approval
#001 — 40MG
RLD
5 patents
0 exclusivities
▴
CAPSULE;ORAL | Approved: Jun 23, 2017
Patents (5)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
7598276
Nov 8, 2026
—
Yes
—
—
—
8404724
Mar 29, 2031
—
—
Yes
U-2034
INHIBITING COAGULATION
—
8557852
Sep 8, 2028
—
—
—
U-1167
PROPHYLAXIS OF DEEP VEIN THROMBOSIS (DVT)
—
8987463
Dec 28, 2030
—
—
Yes
—
—
9555023
Nov 7, 2026
—
—
—
U-1502
PROPHYLAXIS OF PULMONARY EMBOLISM
—
#002 — 80MG
RLD
5 patents
0 exclusivities
▾
CAPSULE;ORAL | Approved: Jun 23, 2017